Literature DB >> 12886054

Antimicrobials as potential adjunctive agents in the treatment of biofilm infection with Staphylococcus epidermidis.

Kyong Ran Peck1, Shin Woo Kim, Sook-In Jung, Yeon-Sook Kim, Won Sup Oh, Ji Young Lee, Joung Hwa Jin, Sungmin Kim, Jae-Hoon Song, Hiroyuki Kobayashi.   

Abstract

BACKGROUND: This study was performed to evaluate the interaction of erythromycin or rifampin with vancomycin against Staphylococcus epidermidis biofilms.
METHODS: Biofilm-forming S. epidermidis strains (ATCC 35983, 35984) and polyurethane (PU) sheets were incubated for the formation of bacterial biofilms. Biofilms on PU sheets were treated with various antibiotic regimens. The number of viable bacteria on the sheets was counted.
RESULTS: While erythromycin or vancomycin alone did not significantly reduce the biofilm bacterial concentration, the combination of vancomycin and erythromycin resulted in a clear reduction in bacterial concentration compared with the single agents. Rifampin was the most active single agent against biofilm-forming S. epidermidis, while the combination of rifampin and vancomycin showed further reduction in bacterial concentration.
CONCLUSIONS: These data suggest that the combination of erythromycin or rifampin and vancomycin is more effective than vancomycin alone in the treatment of biofilm infections caused by biofilm-forming S. epidermidis. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12886054     DOI: 10.1159/000071143

Source DB:  PubMed          Journal:  Chemotherapy        ISSN: 0009-3157            Impact factor:   2.544


  4 in total

Review 1.  Rifampin as adjuvant treatment of Gram-positive bacterial infections: a systematic review of comparative clinical trials.

Authors:  I A Bliziotis; F Ntziora; K R Lawrence; M E Falagas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-12       Impact factor: 3.267

Review 2.  Rifampin combination therapy for nonmycobacterial infections.

Authors:  Graeme N Forrest; Kimberly Tamura
Journal:  Clin Microbiol Rev       Date:  2010-01       Impact factor: 26.132

3.  Effect of a standardized treatment regime for infection after osteosynthesis.

Authors:  Pien Hellebrekers; Luke P H Leenen; Meriam Hoekstra; Falco Hietbrink
Journal:  J Orthop Surg Res       Date:  2017-03-09       Impact factor: 2.359

4.  Extended Release Combination Antibiotic Therapy from a Bone Void Filling Putty for Treatment of Osteomyelitis.

Authors:  Raquib Hasan; Kambri Schaner; Meredith Schroeder; Abbey Wohlers; Jacob Shreffler; Codi Schaper; Hariharaputhiran Subramanian; Amanda Brooks
Journal:  Pharmaceutics       Date:  2019-11-08       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.